BRUSSELS (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent ...
A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...
MORRISTOWN, N.J. — Actavis has launched its version of an epilepsy drug made by UCB. The generic drug maker said it received approval from the Food and Drug Administration for levetiracetam ...
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...
Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...
News-Medical.Net on MSN
Glucose-lowering drugs may reduce risk of developing epilepsy
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...
The antiseizure drugs levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam, generic) and clobazam (Onfi, Sympazan, generic) can cause a rare but serious drug hypersensitivity reaction that can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback